The basic panel of analyses at Biotest Facility consists of the common hematology parameters including three-part differential counts and the clinical chemistry parameters ALB, ALT, BUN, Ca, CHOL, CREA, GLOB, Phos, TBIL and TP. Besides this cost-efficient panel, we offer extensions to the panel and study specific designs.
Clinical adverse symptoms revealed early in the preclinical development, e.g. during administration to rodent research models, are valuable indicators of issues that must be taken care of during the further development. I shall be considered to cover the clinical observations with measurement of hematology parameters and clinical chemistry during one of the very first studies with administrations of the test article to an animal research model.